Data / Form D filings / LivFul Inc.
LivFul Inc.: Form D filings
LivFul Inc., a pharmaceuticals company in Temple, TX, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on December 16, 2025, reports $250,000 sold of a $26 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 S. 1ST STREET, SUITE 225, Temple, TX, 76501
- Phone
- (254) 624-5747
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1845848
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | New notice | $26,000,000 | $250,000 | $25,750,000 | 2 | Dec 8, 2025 | sec.gov |
| Jun 7, 2024 | New notice | $6,500,000 | $125,000 | $6,375,000 | 1 | May 24, 2024 | sec.gov |
| Apr 5, 2023 | Amendment | $5,000,000 | $3,102,750 | $1,897,250 | 13 | May 1, 2022 | sec.gov |
| May 3, 2022 | New notice | $5,000,000 | $750,000 | $4,250,000 | 1 | May 1, 2022 | sec.gov |
| Mar 24, 2021 | New notice | $10,722,500 | $6,660,000 | $4,062,500 | 60 | Mar 22, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hogan Bassey | Executive Officer, Director | |
| Matt Elsberry | Executive Officer, Director | |
| Yaw Nsarkoh | Director | |
| John Manwell | Executive Officer, Director | |
| Kris Maynard | Director | |
| Michael Norman | Executive Officer, Director | |
| Andrew Barlow | Director | |
| Carl Thong | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LivFul Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.